Skip to main content
Premium Trial:

Request an Annual Quote

BD Buys Dynacon's Lab Systems Business

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson said today that its BD Diagnostics segment has acquired Dynacon’s Lab Systems business, which offers microbiology specimen-processing technologies, for an undisclosed sum.

The purchase of the business from privately held Dynacon, which closed on March 29, gives BD Diagnostics two new products, the InocuLab system for processing microbial specimens and the Innova Preanalytical Automated Microbiology Specimen Processor, which is a higher-throughput, automated version of the InocuLab.

BD said that the Innova System accommodates the “full range of microbiology specimen containers, streak patterns, protocols, and workflows.”

Dynacon’s CEO Peter Hughes said that the Innova and the InnocuLab platforms “complement perfectly” BD’s product line in infectious disease testing.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.